Saiju Jacob

Medicine & Life Sciences

1. Myasthenia Gravis 100%
2. eculizumab 59%
3. Cholinergic Receptors 52%
4. Antibodies 48%
5. Chronic Inflammatory Demyelinating Polyradiculoneuropathy 29%
6. Intravenous Immunoglobulins 22%
7. Neuromyelitis Optica 21%
8. Muscles 17%
9. Susac Syndrome 17%
10. Immunoglobulin G 14%
11. Safety 13%
12. Aquaporin 4 13%
13. Muscle Weakness 12%
14. Immunomodulation 11%
15. Placebos 11%
16. Neural Conduction 10%
17. Headache 10%
18. Autoantibodies 10%
19. Transverse Myelitis 10%
20. Neurology 9%
21. Stiff-Person Syndrome 9%
22. 1 Rippling muscle disease 9%
23. Activities of Daily Living 9%
24. Dendroaspis 8%
25. Nonaka type Distal myopathy 8%
26. Retinal Artery Occlusion 8%
27. Limbic Encephalitis 8%
28. Contactins 7%
29. Upper Extremity 7%
30. Phosphotransferases 7%
31. Intracranial Hypertension 7%
32. Neuromuscular Junction 7%
33. Autoimmune Diseases of the Nervous System 7%
34. Amelanotic Melanoma 7%
35. Juvenile Myoclonic Epilepsy 7%
36. Therapeutics 7%
37. Acute Disseminated Encephalomyelitis 7%
38. Muscular Diseases 7%
39. rofecoxib 6%
40. Azathioprine 6%
41. Eye 6%
42. Multiparametric Magnetic Resonance Imaging 6%
43. Ophthalmoplegia 6%
44. Pharmaceutical Preparations 6%
45. Brain 6%
46. Cavernous Sinus 6%
47. Glutens 6%
48. Seizures 6%
49. Passive Immunization 5%
50. Electrophysiology 5%